Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients with undetectable PSA levels.

Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in ...

Self-administered injectable contraceptives, which are progestin-only shots taken at home every three months, have been ...

A nanomaterial based on a platform developed by Professor Samuel Stupp crosses the blood-brain barrier and targets harmful ...

The White House press secretary was one of many Trump administration members to be photographed for the magazine's series of interviews with chief of staff Susie Wiles Celal Gunes/Anadolu via Getty; ...

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug. The Wegovy pill, as it’s called, is first oral version of a GLP-1 drug that ...

Caroline Banton has 6+ years of experience as a writer of business and finance articles. She also writes biographies for Story Terrace. David Kindness is a Certified Public Accountant (CPA) and an ...

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

CHICAGO — Dr. Mark Geier has, he says, solved the riddle of autism. He says he has identified its cause and, in the powerful drug Lupron, found an effective treatment — what he calls a "major ...

H.R. 875 – Jeremy and Angel Seay and Sergeant Brandon Mendoza Protect Our Communities from DUIs Act of 2025 (June 24, 2025) H.R. 275 – Special Interest Alien Reporting Act of 2025 (June 24, 2025) S.J.

Leqvio (inclisiran) is a prescription drug used to help treat certain types of high cholesterol. Leqvio comes in a prefilled syringe for injection under the skin. Leqvio contains the active drug ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Robert Kelly is managing director of ...